Identification of effective features of LFP signal for making closed-loop deep brain stimulation in parkinsonian rats

[1]  H. Soltanian-Zadeh,et al.  Localizing confined epileptic foci in patients with an unclear focus or presumed multifocality using a component-based EEG-fMRI method , 2020, Cognitive Neurodynamics.

[2]  M. Z. Soroush,et al.  Simultaneous EEG-fMRI: A novel approach to localize the Seizure Onset Zone , 2019 .

[3]  H. Soltanian-Zadeh,et al.  Epilepsy Presurgical Evaluation of Patients with Complex Source Localization by a Novel Component-Based EEG-fMRI Approach , 2019, Iranian Journal of Radiology.

[4]  Mohammad Pooyan,et al.  Toward a closed-loop deep brain stimulation in Parkinson's disease using local field potential in parkinsonian rat model. , 2019, Medical hypotheses.

[5]  Franz Hell,et al.  Deep Brain Stimulation Programming 2.0: Future Perspectives for Target Identification and Adaptive Closed Loop Stimulation , 2019, Front. Neurol..

[6]  A. Lozano,et al.  Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments , 2019, EMBO molecular medicine.

[7]  J. Neimat,et al.  A Review of Biomarkers Use in Parkinson with Deep Brain Stimulation: A Successful Past Promising a Bright Future. , 2019, World neurosurgery.

[8]  H. Bergman,et al.  Deep brain stimulation: current challenges and future directions , 2019, Nature Reviews Neurology.

[9]  Yasin Temel,et al.  An update on adaptive deep brain stimulation in Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[10]  Mohammad Sajad Manuchehri,et al.  A time local subset feature selection for prediction of sudden cardiac death from ECG signal , 2018, Medical & Biological Engineering & Computing.

[11]  P. Ghasemi,et al.  Closed- and Open-loop Deep Brain Stimulation: Methods, Challenges, Current and Future Aspects , 2018, Journal of biomedical physics & engineering.

[12]  D. Zhao,et al.  Extraction of Parkinson’s Disease-Related Features from Local Field Potentials for Adaptive Deep Brain Stimulation , 2018, Neurophysiology.

[13]  Robert E. Hampson,et al.  Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank , 2018, Front. Neurosci..

[14]  H. Fernandez,et al.  DBS Programming: An Evolving Approach for Patients with Parkinson's Disease , 2017, Parkinson's disease.

[15]  Mahboubeh Parastarfeizabadi,et al.  Advances in closed-loop deep brain stimulation devices , 2017, Journal of NeuroEngineering and Rehabilitation.

[16]  J. Volkmann,et al.  Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α‐synuclein Parkinson's disease rat model , 2017, Annals of neurology.

[17]  Seong Hoon Jeong,et al.  Altered cardiorespiratory coupling in young male adults with excessive online gaming , 2015, Biological Psychology.

[18]  Karl J. Friston,et al.  LFP and oscillations—what do they tell us? , 2015, Current Opinion in Neurobiology.

[19]  Thomas V. Wiecki,et al.  Model-Based Cognitive Neuroscience Approaches to Computational Psychiatry , 2015 .

[20]  Bin Deng,et al.  Closed-Loop Control of Tremor-Predominant Parkinsonian State Based on Parameter Estimation , 2015, IEEE Transactions on Neural Systems and Rehabilitation Engineering.

[21]  A. Priori,et al.  Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations , 2013, Experimental Neurology.

[22]  Tipu Z. Aziz,et al.  Parkinson's Disease tremor classification - A comparison between Support Vector Machines and neural networks , 2012, Expert Syst. Appl..

[23]  P. Brown,et al.  Brain Stimulation in Neurology and Psychiatry , 2012, Annals of the New York Academy of Sciences.

[24]  S. Haber,et al.  Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism , 2011, Neuron.

[25]  J. Brotchie,et al.  Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein , 2011, PloS one.

[26]  J. Brotchie,et al.  Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease , 2010, Molecular Neurodegeneration.

[27]  C. Sortwell,et al.  A functionally relevant and long‐term model of deep brain stimulation of the rat subthalamic nucleus: advantages and considerations , 2010, The European journal of neuroscience.

[28]  M. Roghani,et al.  Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism , 2010, Brain Research Bulletin.

[29]  M. Behbehani,et al.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss , 2010, Neurobiology of Disease.

[30]  Peter Brown,et al.  Value of subthalamic nucleus local field potentials recordings in predicting stimulation parameters for deep brain stimulation in Parkinson's disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  A Schnitzler,et al.  Review: Deep brain stimulation in Parkinson’s disease , 2009, Therapeutic advances in neurological disorders.

[32]  Grant D. Huang,et al.  Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. , 2009, JAMA.

[33]  E. Martignoni,et al.  The 6-hydroxydopamine model: news from the past. , 2008, Parkinsonism & related disorders.

[34]  A. Benabid,et al.  Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. , 2007, Brain : a journal of neurology.

[35]  H. Steinbusch,et al.  Protection of nigral cell death by bilateral subthalamic nucleus stimulation , 2006, Brain Research.

[36]  G. Meredith,et al.  Behavioral models of Parkinson's disease in rodents: A new look at an old problem , 2006, Movement disorders : official journal of the Movement Disorder Society.

[37]  Y. Agid,et al.  Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[38]  D. Prou,et al.  Toxin-induced models of Parkinson’s disease , 2005, NeuroRX.

[39]  M. Joghataie,et al.  Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence. , 2004, Parkinsonism & related disorders.

[40]  M. Roghani,et al.  Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test , 2004, Physiology & Behavior.

[41]  Y. Kajita,et al.  Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. , 2004, Journal of neurosurgery.

[42]  A. Benabid,et al.  Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical Studies , 1996, The European journal of neuroscience.

[43]  A. Wolf,et al.  Determining Lyapunov exponents from a time series , 1985 .

[44]  Marianna Amboni,et al.  Depression, Apathy, Anhedonia, and Fatigue in Parkinson’s Disease , 2015 .